Gut Microbiota and Coronary Artery Disease: Current Therapeutic Perspectives

Gut Microbiota and Coronary Artery Disease: Current Therapeutic Perspectives

The human gut microbiota is the community of microorganisms living in the human gut. This microbial ecosystem contains bacteria beneficial to their host and plays important roles in human physiology, participating in energy harvest from indigestible fiber, vitamin synthesis, and regulation of the im...

Full description

Bibliographic Details
Main Authors:	Themistoklis Katsimichas, Panagiotis Theofilis, Konstantinos Tsioufis, Dimitris Tousoulis
Format:	Article
Language:	English
Published:	MDPI AG 2023-02-01
Series:	Metabolites
Subjects:	gut microbiota TMAO probiotics prebiotics synbiotics coronary artery disease
Online Access:	https://www.mdpi.com/2218-1989/13/2/256

Similar Items

Effects and Mechanisms of Probiotics, Prebiotics, Synbiotics, and Postbiotics on Metabolic Diseases Targeting Gut Microbiota: A Narrative Review
by: Hang-Yu Li, et al.
Published: (2021-09-01)

Effects of the Human Gut Microbiota on Cognitive Performance, Brain Structure and Function: A Narrative Review
by: Katie Louise Tooley
Published: (2020-09-01)

Gut microbiota modulation in the chronic kidney disease management
by: Łukasz Dobrek
Published: (2022-03-01)

Effects of a high-prebiotic diet versus probiotic supplements versus synbiotics on adult mental health: The “Gut Feelings” randomised controlled trial
by: Tanya M. Freijy, et al.
Published: (2023-02-01)

Effect of a Multispecies Synbiotic Supplementation on Body Composition, Antioxidant Status, and Gut Microbiomes in Overweight and Obese Subjects: A Randomized, Double-Blind, Placebo-Controlled Study
by: Piyarat Oraphruek, et al.
Published: (2023-04-01)

Gastrointestinal Microbiota and Their Manipulation for Improved Growth and Performance in Chickens
by: Shahna Fathima, et al.
Published: (2022-05-01)

Effect of prebiotics, probiotics, synbiotics on depression: results from a meta-analysis
by: Qin Zhang, et al.
Published: (2023-06-01)

Synbiotic Supplementation Modulates Gut Microbiota, Regulates β-Catenin Expression and Prevents Weight Gain in ob/ob Mice: Preliminary Findings
by: Sebastião Mauro B. Duarte, et al.
Published: (2022-09-01)

The Impact of Probiotics, Prebiotics, and Synbiotics during Pregnancy or Lactation on the Intestinal Microbiota of Children Born by Cesarean Section: A Systematic Review
by: Sandra Martín-Peláez, et al.
Published: (2022-01-01)

Pancreatic Cancer and Gut Microbiome-Related Aspects: A Comprehensive Review and Dietary Recommendations
by: Bartosz Kamil Sobocki, et al.
Published: (2021-12-01)

Gut microbiome-targeted therapies for Alzheimer’s disease
by: Tao Zhang, et al.
Published: (2023-12-01)

Biotics in pediatrics: Separating hype from reality
by: Hania Szajewska
Published: (2024-03-01)

Synbiotic Agents and Their Active Components for Sustainable Aquaculture: Concepts, Action Mechanisms, and Applications
by: Vijayaram Srirengaraj, et al.
Published: (2023-12-01)

Prebiotics, Probiotics, and Synbiotics—A Research Hotspot for Pediatric Obesity
by: Reka Borka Balas, et al.
Published: (2023-10-01)

Intestinal microbiota and immunity. Possibilities of multistrain probiotics in the correction of immune status in children
by: T. A. Chebotareva
Published: (2021-08-01)

Probiotics, Prebiotics, Synbiotics, and Fermented Foods as Potential Biotics in Nutrition Improving Health via Microbiome-Gut-Brain Axis
by: Divakar Dahiya, et al.
Published: (2022-06-01)

Alteration of Gut Microbiota in Inflammatory Bowel Disease (IBD): Cause or Consequence? IBD Treatment Targeting the Gut Microbiome
by: Israr Khan, et al.
Published: (2019-08-01)

Treatment of Dyslipidemia through Targeted Therapy of Gut Microbiota
by: Brandon Flaig, et al.
Published: (2023-01-01)

Co-Encapsulated Synbiotics and Immobilized Probiotics in Human Health and Gut Microbiota Modulation
by: Monika Kvakova, et al.
Published: (2021-06-01)

The Interplay between Cardiovascular Disease, Exercise, and the Gut Microbiome
by: Candace R. Longoria, et al.
Published: (2022-10-01)

Prebiotics Plus Probiotics May Favorably Impact on Gut Permeability, Endocannabinoid Receptors, and Inflammatory Biomarkers in Patients with Coronary Artery Diseases: A Clinical Trial
by: Min Liu, et al.
Published: (2024-02-01)

Gastrointestinal Microbiome and Multiple Health Outcomes: Umbrella Review
by: Chengting Chang, et al.
Published: (2022-09-01)

Evaluation of the Prebiotic Potential of a Commercial Synbiotic Food Ingredient on Gut Microbiota in an Ex Vivo Model of the Human Colon
by: Walid Mottawea, et al.
Published: (2020-09-01)

Optimization of Mixed Inulin, Fructooligosaccharides, and Galactooligosaccharides as Prebiotics for Stimulation of Probiotics Growth and Function
by: Ekkachai Kaewarsar, et al.
Published: (2023-04-01)

<i>Lacticaseibacillus rhamnosus</i> ATCC 53103 and <i>Limosilactobacillus reuteri</i> ATCC 53608 Synergistically Boost Butyrate Levels upon Tributyrin Administration Ex Vivo
by: Pieter Van den Abbeele, et al.
Published: (2023-03-01)

Intake of MPRO3 over 4 Weeks Reduces Glucose Levels and Improves Gastrointestinal Health and Metabolism
by: Songhee Lee, et al.
Published: (2021-12-01)

The effects of probiotics, prebiotics, and synbiotics on polycystic ovarian syndrome: an overview of systematic reviews
by: Pooneh Angoorani, et al.
Published: (2023-06-01)

Reviewing the Potential Therapeutic Approaches Targeting the Modulation of Gastrointestinal Microflora in Schizophrenia
by: Ilinca-Bianca Nita, et al.
Published: (2022-12-01)

Prebiotic, Probiotic, and Synbiotic Consumption Alter Behavioral Variables and Intestinal Permeability and Microbiota in BTBR Mice
by: Jodi E. Nettleton, et al.
Published: (2021-08-01)

The role of gut microbiota in gout: Is gut microbiota a potential target for gout treatment
by: Shuting Tong, et al.
Published: (2022-11-01)

Overview of the Importance of Biotics in Gut Barrier Integrity
by: Aleksandra Maria Kocot, et al.
Published: (2022-03-01)

Dietary Fat Modulation of Gut Microbiota and Impact on Regulatory Pathways Controlling Food Intake
by: Sevag Hamamah, et al.
Published: (2023-07-01)

Interplay of Gut Microbiota in Polycystic Ovarian Syndrome: Role of Gut Microbiota, Mechanistic Pathways and Potential Treatment Strategies
by: Leander Corrie, et al.
Published: (2023-01-01)

Gut microbiota therapy for nonalcoholic fatty liver disease: Evidence from randomized clinical trials
by: Ting-Rui Han, et al.
Published: (2023-01-01)

The synergistic synbiotic potential of 1-kestose and Bifidobacterium longum in the mouse gut
by: Ayako Watanabe, et al.
Published: (2023-02-01)

Potential use of synbiotics in ENT diseases
by: T. I. Garashchenko, et al.
Published: (2020-05-01)

Healthy intestinal colonization in children: strong immunity
by: N. L. Pakhomovskaya, et al.
Published: (2018-10-01)

The Impact of Cytokines in Coronary Atherosclerotic Plaque: Current Therapeutic Approaches
by: Panagiotis Tsioufis, et al.
Published: (2022-12-01)

A Current Review on the Role of Prebiotics in Colorectal Cancer
by: Anna Shrifteylik, et al.
Published: (2023-08-01)

Gut microbiome-targeted therapies in liver cirrhosis: a protocol for systematic review and meta-analysis
by: Honglin Jiang, et al.
Published: (2022-08-01)